IJH vs XLV
iShares Core S&P Mid-Cap ETF vs Health Care Select Sector SPDR Fund
- • IJH has the lower expense ratio at 0.05% vs 0.08% for XLV.
- • XLV pays a higher dividend yield (1.38%).
Side-by-side metrics
| Metric | IJH | XLV |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.05% | 0.08% |
Dividend yield Trailing 12-month yield. | 1.23% | 1.38% |
AUM Assets under management — bigger funds are typically more liquid. | $123.20B | $49.10B |
YTD return | 13.60% | 23.16% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.99 | 0.41 |
P/E ratio | 19.23 | 30.63 |
Last price | $74.78 | $187.94 |
Inception | — | — |
Issuer | iShares | State Street |
IJH top holdings
| OKTA | Okta Inc Class A | 1.01% |
| FTI | TechnipFMC PLC | 0.79% |
| UTHR | United Therapeutics Corp | 0.75% |
| ENTG | Entegris Inc | 0.69% |
| ATI | ATI Inc | 0.66% |
| USFD | US Foods Holding Corp | 0.65% |
| RS | Reliance Inc | 0.65% |
| XPO | XPO Inc | 0.65% |
| THC | Tenet Healthcare Corp | 0.64% |
| PR | Permian Resources Corp Class A | 0.64% |
XLV top holdings
| LLY | Eli Lilly and Co | 16.88% |
| JNJ | Johnson & Johnson | 9.80% |
| ABBV | AbbVie Inc | 7.76% |
| MRK | Merck & Co Inc | 5.49% |
| UNH | UnitedHealth Group Inc | 5.44% |
| TMO | Thermo Fisher Scientific Inc | 3.84% |
| AMGN | Amgen Inc | 3.75% |
| GILD | Gilead Sciences Inc | 3.15% |
| ABT | Abbott Laboratories | 2.74% |
| PFE | Pfizer Inc | 2.59% |
About IJH
IJH (iShares Core S&P Mid-Cap ETF) is Tracks the S&P MidCap 400 index. Managed by iShares, the fund carries $123.2B in assets under management, an expense ratio of 0.05%, a dividend yield of 1.23%. Its largest holding is Okta Inc Class A (OKTA), which represents 1.0% of the portfolio. Real Estate is the fund's largest sector exposure at 8.0%.
About XLV
XLV (Health Care Select Sector SPDR Fund) is S&P 500 health care sector. Managed by State Street, the fund carries $49.1B in assets under management, an expense ratio of 0.08%, a dividend yield of 1.38%. Its largest holding is Eli Lilly and Co (LLY), which represents 16.9% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.